CN113227075A - 用于产生n,n’-双[2-(1h-咪唑-4-基)乙基]丙二酰胺的新方法 - Google Patents

用于产生n,n’-双[2-(1h-咪唑-4-基)乙基]丙二酰胺的新方法 Download PDF

Info

Publication number
CN113227075A
CN113227075A CN201980086518.2A CN201980086518A CN113227075A CN 113227075 A CN113227075 A CN 113227075A CN 201980086518 A CN201980086518 A CN 201980086518A CN 113227075 A CN113227075 A CN 113227075A
Authority
CN
China
Prior art keywords
bis
histamine
malonamide
imidazol
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980086518.2A
Other languages
English (en)
Chinese (zh)
Inventor
弗拉迪米尔·叶夫根尼耶维奇·涅博利辛
塔季亚纳·亚历山德罗芙娜·克罗莫瓦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vladimir Yevgeniyevich Neborisin
Valenta Intellect LLC
Original Assignee
Pharmenterprises OOO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmenterprises OOO filed Critical Pharmenterprises OOO
Publication of CN113227075A publication Critical patent/CN113227075A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN201980086518.2A 2018-10-29 2019-10-25 用于产生n,n’-双[2-(1h-咪唑-4-基)乙基]丙二酰胺的新方法 Pending CN113227075A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2018138004A RU2679636C1 (ru) 2018-10-29 2018-10-29 Новый способ получения n,n'-бис[2-(1н-имидазол-4-ил)этил]малонамида
RU2018138004 2018-10-29
PCT/RU2019/050199 WO2020091632A1 (ru) 2018-10-29 2019-10-25 Новый способ получения n,n'-бис[2-(1н-имидазол-4-ил)этил]малонамида

Publications (1)

Publication Number Publication Date
CN113227075A true CN113227075A (zh) 2021-08-06

Family

ID=65442779

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980086518.2A Pending CN113227075A (zh) 2018-10-29 2019-10-25 用于产生n,n’-双[2-(1h-咪唑-4-基)乙基]丙二酰胺的新方法

Country Status (4)

Country Link
CN (1) CN113227075A (ru)
EA (1) EA202191158A1 (ru)
RU (1) RU2679636C1 (ru)
WO (1) WO2020091632A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2745265C2 (ru) * 2019-09-12 2021-03-22 Общество С Ограниченной Ответственностью "Валента - Интеллект" Новые составы 2-(имидазол-4-ил)-этанамида пентандиовой-1,5 кислоты для лечения и профилактики вирусных заболеваний
WO2023224519A1 (ru) * 2022-05-19 2023-11-23 Общество С Ограниченной Ответственностью "Валента-Интеллект" Новая кристаллическая форма n,n'-бис-[2-(1н-имидазол-4-ил)этил]пропандиамида и ее фармацевтическое применение

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105358548A (zh) * 2013-04-12 2016-02-24 制药有限责任公司 二羧酸双酰胺衍生物、其用途、基于其的药物组合物和用于生产二羧酸双酰胺衍生物的方法
WO2017205622A1 (en) * 2016-05-25 2017-11-30 Savant Neglected Diseases, Llc Method of making benznidazole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2287524C1 (ru) * 2005-03-31 2006-11-20 ООО "Фарминтерпрайсез" Аспартильные производные гистамина, способ их получения, фармацевтическая композиция и их применение в качестве модуляторов активности ферментов антиоксидантной защиты

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105358548A (zh) * 2013-04-12 2016-02-24 制药有限责任公司 二羧酸双酰胺衍生物、其用途、基于其的药物组合物和用于生产二羧酸双酰胺衍生物的方法
CN109134378A (zh) * 2013-04-12 2019-01-04 特拉米德医疗有限责任公司 二羧酸双酰胺衍生物、其用途和基于其的药物组合物
WO2017205622A1 (en) * 2016-05-25 2017-11-30 Savant Neglected Diseases, Llc Method of making benznidazole

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
项东升;: "N,N\'-二苯基丙二酰胺的合成新工艺", 化工中间体, no. 06, pages 4 - 6 *

Also Published As

Publication number Publication date
RU2679636C1 (ru) 2019-02-12
WO2020091632A1 (ru) 2020-05-07
EA202191158A1 (ru) 2021-07-20

Similar Documents

Publication Publication Date Title
CN103080100B (zh) 1-三唑-2-丁醇衍生物的制造方法
US10040778B2 (en) Anhydrous lenalidomide form-I
JP5881691B2 (ja) キノリン−3−カルボキサミドの製造方法
CN113227075A (zh) 用于产生n,n’-双[2-(1h-咪唑-4-基)乙基]丙二酰胺的新方法
JP6985179B2 (ja) プロリンアミド化合物の製造方法
EP2066623A1 (en) Process for producing 1-(3,4-dichlorobenzyl)-5-octylbiguanide or a salt thereof
JP2005507900A (ja) シタロプラムの製造方法
CN106699595A (zh) 一种拉科酰胺制备方法
CN116082234A (zh) 一种[(4-羟基-1-甲基-7-苯氧基异喹啉-3-甲酰基)氨基]乙酸的制备方法
EP2307354B1 (en) Process for preparing a benzoylbenzeneacetamide derivative
CN112272665B (zh) 制备立他司特的方法
JP2002512223A (ja) 純粋な鏡像体であるn−メチル−n−[(1s)−1−フェニル−2−((3s)−3−ヒドロキシピロリジン−1−イル)エチル]−2,2−ジフェニルアセトアミドの製造方法
JP2023529877A (ja) 結晶形のラベキシモドの調製方法
WO2017167949A1 (en) Crystalline forms of bilastine
JP2020535192A (ja) レナリドミドの結晶形
EA040924B1 (ru) Новый способ получения n,n'-бис[2-(1н-имидазол-4-ил)этил]малонамида
WO2023140809A1 (en) Novel polymorph of vismodegib and method of preparation
JP7536950B2 (ja) プロリンアミド化合物の製造方法
KR20120113263A (ko) 인다졸-3-카르복실산 및 n-(s)-1-아자바이사이클로[2.2.2]옥트-3-일-1h-인다졸-3-카르복사미드 하이드로클로라이드 염의 제조 방법
WO2022271109A1 (en) New polymorph of vismodegib and method for its preparation
JP2717995B2 (ja) 1,2,3−トリアゾールの製法
JP2024058272A (ja) 1-アルキル-5-ヒドロキシピラゾールの製造方法
JP2022025121A (ja) プロリンアミド化合物の製造方法
WO2022250620A1 (en) An improved process for highly pure benserazide hydrochloride and novel anhydrous polymorph thereof
WO2023121574A1 (en) Novel polymorph of ruxolitinib hemifumarate and method of preparation

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40058965

Country of ref document: HK

TA01 Transfer of patent application right

Effective date of registration: 20221114

Address after: Moscow, Russia

Applicant after: LTD "VALENTA-INTELLEKT"

Applicant after: Vladimir Yevgeniyevich Neborisin

Address before: Moscow, Russia

Applicant before: OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU "PHARMENTERPRISES"

TA01 Transfer of patent application right